Sign in
Active, not recruitingPhase 4

Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children

Key facts

Who runs it
Udayana University
Where
Indonesia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
Phase
Phase 4
People taking part
72 people, planned
Started
13 Dec 2024
Ended
13 Feb 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children
  • Nebulized 0.9% Normal Saline
Record updated
22 January 2025

Who can take part

Age
2 years to 6 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Pediatric patients aged 2 to 6 years old
  • Planned general anesthesia using inhalation sevoflurane with endotracheal tube techniques
  • Parents agree to participate in the study

Who cannot take part

  • Emergency surgery
  • History of upper respiratory infection within 2 weeks before the procedure
  • Surgery duration estimation exceeding 180 minutes
  • history or diagnosed with mental or cognitive disorders
  • History of allergy to dexmedetomidine
  • Pediatric patients with > ASA II
  • Difficult airway management
  • Congenital abnormalities of vital organs
  • Malnutrition
  • Parents refuse to participate in the study

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Analyzing the effectiveness of nebulized dexmedetomidine 2 mcg/kg in reducing the incidence of post-anesthesia delirium in preschool children undergoing elective surgery with sevoflurane inhalation general anesthesia.

Read full original descriptionShow less

Researchers will compare nebulized Dexmedetomidine to a placebo (a look-alike substance that contains no drug) to see if the drug can reduce post anesthesia delirium incidence.

The 2 groups in the trial

  • Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool ChildrenExisting treatment, for comparison

    Nebulization with the anesthetic drug dexmedetomidine at a dose of 2 mcg/kg body weight, diluted to 3 ml with 0.9% normal saline, administered before the induction of anesthesia in the reception area. After the anesthesia, primary data collection is conducted by recovery room staff who are blinded to the treatment and control groups. Data includes scores or levels of post-anesthesia delirium or agitation assessed using the pediatric anesthesia emergence delirium score (PAED score) at 15, 30, 60, and 120 minutes post-surgery in the recovery room.

  • Nebulized Normal Saline 0.9% for Post-Anesthesia Delirium in Preschool ChildrenPlacebo, for comparison

    Nebulization with normal saline 0.9% 3ml, administered before the induction of anesthesia in the reception area. After the anesthesia, primary data collection is conducted by recovery room staff who are blinded to the treatment and control groups. Data includes scores or levels of post-anesthesia delirium or agitation assessed using the pediatric anesthesia emergence delirium score (PAED score) at 15, 30, 60, and 120 minutes post-surgery in the recovery room.

    Treatment: Nebulized 0.9% Normal Saline

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Nebulized Dexmedetomidine to Reduce Post-Anesthesia Delirium of Sevoflurane in Preschool Children Undergoing Elective Surgery
Record updated
22 January 2025